All eyes are on Alnylam as the company awaits entry into the transthyretin amyloid cardiomyopathy market, which currently ...

Ed Kaye, former CEO of Sarepta Therapeutics, is stepping down from his current role as chief executive of a Boston-area ...

HC Bioscience is shutting down after conducting preclinical models for a transfer RNA (tRNA) asset designed to treat ...

Cambridge University researchers have uncovered evidence that two distinct populations of ancient hominins, separated for ...

Kei Sato was looking for his next big challenge five years ago when it smacked him — and the world — in the face. The ...

But real lightning would have struck infrequently—and mostly in open ocean, where organic compounds would have quickly ...

NASA’s OSIRIS-REx mission returned samples from asteroid Bennu, which showed discoveries about life and the early solar ...

In this deep dive, BioSpace explores the diverse therapeutic modalities now in development, as well as the opportunities and ...

With clinical trials results trickling in, “antiaging” drugs that clear away senescent cells are proving to be promising — ...

We may be starting to get a grasp on what kick-started life on Earth – and it could help us search for it on other planets ...